227 related articles for article (PubMed ID: 30294327)
1. Functional Inhibitory Siglec-6 Is Upregulated in Human Colorectal Cancer-Associated Mast Cells.
Yu Y; Blokhuis BRJ; Diks MAP; Keshavarzian A; Garssen J; Redegeld FA
Front Immunol; 2018; 9():2138. PubMed ID: 30294327
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement.
Yokoi H; Choi OH; Hubbard W; Lee HS; Canning BJ; Lee HH; Ryu SD; von Gunten S; Bickel CA; Hudson SA; Macglashan DW; Bochner BS
J Allergy Clin Immunol; 2008 Feb; 121(2):499-505.e1. PubMed ID: 18036650
[TBL] [Abstract][Full Text] [Related]
3. Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.
Bochner BS
Clin Exp Allergy; 2009 Mar; 39(3):317-24. PubMed ID: 19178537
[TBL] [Abstract][Full Text] [Related]
4. Siglec-5 is an inhibitory immune checkpoint molecule for human T cells.
Vuchkovska A; Glanville DG; Scurti GM; Nishimura MI; White P; Ulijasz AT; Iwashima M
Immunology; 2022 Jun; 166(2):238-248. PubMed ID: 35290663
[TBL] [Abstract][Full Text] [Related]
5. Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells.
Yokoi H; Myers A; Matsumoto K; Crocker PR; Saito H; Bochner BS
Allergy; 2006 Jun; 61(6):769-76. PubMed ID: 16677248
[TBL] [Abstract][Full Text] [Related]
6. Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells.
Robida PA; Rische CH; Morgenstern NB; Janarthanam R; Cao Y; Krier-Burris RA; Korver W; Xu A; Luu T; Schanin J; Leung J; Rothenberg ME; Wechsler JB; Youngblood BA; Bochner BS; O'Sullivan JA
Cells; 2022 Mar; 11(7):. PubMed ID: 35406705
[TBL] [Abstract][Full Text] [Related]
7. Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated
Lamprinaki D; Garcia-Vello P; Marchetti R; Hellmich C; McCord KA; Bowles KM; Macauley MS; Silipo A; De Castro C; Crocker PR; Juge N
Front Immunol; 2021; 12():744184. PubMed ID: 34659241
[No Abstract] [Full Text] [Related]
8. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
[TBL] [Abstract][Full Text] [Related]
9. Colonic epithelial cells express specific ligands for mucosal macrophage immunosuppressive receptors siglec-7 and -9.
Miyazaki K; Sakuma K; Kawamura YI; Izawa M; Ohmori K; Mitsuki M; Yamaji T; Hashimoto Y; Suzuki A; Saito Y; Dohi T; Kannagi R
J Immunol; 2012 May; 188(9):4690-700. PubMed ID: 22467657
[TBL] [Abstract][Full Text] [Related]
10. Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes.
Varchetta S; Brunetta E; Roberto A; Mikulak J; Hudspeth KL; Mondelli MU; Mavilio D
PLoS One; 2012; 7(9):e45821. PubMed ID: 23029261
[TBL] [Abstract][Full Text] [Related]
11. Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients.
Benmerzoug S; Chevalier MF; Verardo M; Nguyen S; Cesson V; Schneider AK; Dartiguenave F; Rodrigues-Dias SC; Lucca I; Jichlinski P; Roth B; Nardelli-Haefliger D; Derré L
Eur Urol Focus; 2022 May; 8(3):748-751. PubMed ID: 34147404
[TBL] [Abstract][Full Text] [Related]
12. The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation.
Korver W; Wong A; Gebremeskel S; Negri GL; Schanin J; Chang K; Leung J; Benet Z; Luu T; Brock EC; Luehrsen K; Xu A; Youngblood BA
Front Immunol; 2022; 13():833728. PubMed ID: 35154156
[TBL] [Abstract][Full Text] [Related]
13. Viewing Siglecs through the lens of tumor immunology.
Fraschilla I; Pillai S
Immunol Rev; 2017 Mar; 276(1):178-191. PubMed ID: 28258691
[TBL] [Abstract][Full Text] [Related]
14. An anti-siglec-8 antibody depletes sputum eosinophils from asthmatic subjects and inhibits lung mast cells.
Kerr SC; Gonzalez JR; Schanin J; Peters MC; Lambrecht BN; Brock EC; Charbit A; Ansel KM; Youngblood BA; Fahy JV
Clin Exp Allergy; 2020 Aug; 50(8):904-914. PubMed ID: 32542913
[TBL] [Abstract][Full Text] [Related]
15. Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9.
Ikehara Y; Ikehara SK; Paulson JC
J Biol Chem; 2004 Oct; 279(41):43117-25. PubMed ID: 15292262
[TBL] [Abstract][Full Text] [Related]
16. Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer.
Läubli H; Pearce OM; Schwarz F; Siddiqui SS; Deng L; Stanczak MA; Deng L; Verhagen A; Secrest P; Lusk C; Schwartz AG; Varki NM; Bui JD; Varki A
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14211-6. PubMed ID: 25225409
[TBL] [Abstract][Full Text] [Related]
17. Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus.
Ali SR; Fong JJ; Carlin AF; Busch TD; Linden R; Angata T; Areschoug T; Parast M; Varki N; Murray J; Nizet V; Varki A
J Exp Med; 2014 Jun; 211(6):1231-42. PubMed ID: 24799499
[TBL] [Abstract][Full Text] [Related]
18. Leveraging Siglec-8 endocytic mechanisms to kill human eosinophils and malignant mast cells.
O'Sullivan JA; Carroll DJ; Cao Y; Salicru AN; Bochner BS
J Allergy Clin Immunol; 2018 May; 141(5):1774-1785.e7. PubMed ID: 28734845
[TBL] [Abstract][Full Text] [Related]
19. Regulation of mast cells by overlapping but distinct protein interactions of Siglec-6 and Siglec-8.
Korver W; Benet Z; Wong A; Negri GL; Chang K; Sanchez R; Leung J; De Freitas N; Luu T; Schanin J; Youngblood BA
Allergy; 2024 Mar; 79(3):629-642. PubMed ID: 38186079
[TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation.
Schanin J; Gebremeskel S; Korver W; Falahati R; Butuci M; Haw TJ; Nair PM; Liu G; Hansbro NG; Hansbro PM; Evensen E; Brock EC; Xu A; Wong A; Leung J; Bebbington C; Tomasevic N; Youngblood BA
Mucosal Immunol; 2021 Mar; 14(2):366-376. PubMed ID: 32814824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
